MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jpids/piaf081

Медицинская библиотека · Journal of the Pediatric Infectious Diseases Society · 2025

Antifungal Prescribing in European Pediatric Intensive Care Units: Results of a Multinational 3-Month Weekly Point-Prevalence Survey†.

Chorafa Elisavet, Iosifidis Elias, Alkhaaldi Aisha Abdalla, Arias Ana, Cetin Benhur Sirvan, De Luca Maia, Emonts Marieke, Ferreras-Antolin Laura, Ghimenton-Walters Elisabetta, Grasa Carlos D, Groll Andreas H, Herrera-Castillo Laura, Lehrnbecher Thomas, Manzanares Angela, Masjosthusmann Katja, Melendo Susana, Mendoza-Palomar Natalia, Paulus Stéphane, Rincón-López Elena, Romani Lorenza, Sdougka Maria, Solopova Galina, Strenger Volker, Tedford Kara, Tzika Christina, Warris Adilia, Zsigmond Borbala, Roilides Emmanuel

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Critically ill pediatric patients admitted to the pediatric intensive care unit (PICU) are highly vulnerable to infections, including invasive fungal diseases and antifungal agents are frequently prescribed. Little is known about antifungal usage in PICUs across Europe.

METHODS

A multinational 3-month weekly point-prevalence study for measuring antifungal drug use was organized. Eigtheen PICUs (16 hospitals) in 10 countries in the European region participated. All patients hospitalized in the participating PICUs and receiving systemic antifungals were included. Information about ward demographics was collected once; weekly ward and patient data were collected prospectively for the 12-week study period and entered in REDCap database.

RESULTS

Among 18 PICUs, 8 (44%) followed prophylactic practices for targeted group of patients, 7/18 (39%) had an antifungal stewardship program and the majority (16/18, 89%) had the capacity of biomarker utilization (16/16 galactomannan, 13/16 beta-D-glucan, and 9/16 pan-fungal PCR). One hundred one courses in equal number of patients were recorded; 14 for patients aged <3 month, 87 for patients ≥3 month. Malignancy was the most common underlying condition among patients aged ≥3 month (29%) followed by surgery/trauma (25%), whereas all patients <3 month had undergone a recent surgery. Indication for antifungal prescribing was prophylaxis in 38% and treatment in 62% [empirical (57%), preemptive (13%), and targeted (30%)]. Fluconazole was the most common agent both for prophylaxis and treatment, whereas liposomal amphotericin B was the most frequent agent for targeted treatment. The majority (63%) of patients on prophylaxis were oncology or transplant patients. Common reasons for empirical and targeted treatment were persistent fever/other signs of infections in high-risk patients (61%) and Candida infections (100%), respectively. For targeted treatment, the most frequent pathogens were Candida albicans (37%) and Candida parapsilosis (32%).

CONCLUSIONS

Most antifungal prescriptions across European PICUs were for treatment. Fluconazole was the most frequently prescribed antifungal. These surveillance data can guide antifungal stewardship strategies in PICUs.

Для цитирования: Chorafa Elisavet, Iosifidis Elias, Alkhaaldi Aisha Abdalla, Arias Ana, Cetin Benhur Sirvan, De Luca Maia, Emonts Marieke, Ferreras-Antolin Laura, Ghimenton-Walters Elisabetta, Grasa Carlos D, Groll Andreas H, Herrera-Castillo Laura, Lehrnbecher Thomas, Manzanares Angela, Masjosthusmann Katja, Melendo Susana, Mendoza-Palomar Natalia, Paulus Stéphane, Rincón-López Elena, Romani Lorenza, Sdougka Maria, Solopova Galina, Strenger Volker, Tedford Kara, Tzika Christina, Warris Adilia, Zsigmond Borbala, Roilides Emmanuel. Antifungal Prescribing in European Pediatric Intensive Care Units: Results of a Multinational 3-Month Weekly Point-Prevalence Survey†.. Journal of the Pediatric Infectious Diseases Society. 2025. DOI: 10.1093/jpids/piaf081.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.